Kato (Hong Kong) Holdings Limited (2189.HK)

HKD 0.45

(1.14%)

EBITDA Summary of Kato (Hong Kong) Holdings Limited

  • Kato (Hong Kong) Holdings Limited's latest annual EBITDA in 2023 was 133.61 Million HKD , down -43.08% from previous year.
  • Kato (Hong Kong) Holdings Limited's latest quarterly EBITDA in 2023 FY was N/A , down -43.08% from previous quarter.
  • Kato (Hong Kong) Holdings Limited reported an annual EBITDA of 206.89 Million HKD in 2022, up 22.36% from previous year.
  • Kato (Hong Kong) Holdings Limited reported an annual EBITDA of 161.67 Million HKD in 2021, up 15.32% from previous year.
  • Kato (Hong Kong) Holdings Limited reported a quarterly EBITDA of 31.36 Million HKD for 2023 Q4, down 0.0% from previous quarter.
  • Kato (Hong Kong) Holdings Limited reported a quarterly EBITDA of 33.49 Million HKD for 2023 Q2, down 0.0% from previous quarter.

Annual EBITDA Chart of Kato (Hong Kong) Holdings Limited (2023 - 2015)

Historical Annual EBITDA of Kato (Hong Kong) Holdings Limited (2023 - 2015)

Year EBITDA EBITDA Growth
2023 133.61 Million HKD -43.08%
2022 206.89 Million HKD 22.36%
2021 161.67 Million HKD 15.32%
2020 131.87 Million HKD 37.72%
2019 90.9 Million HKD 46.0%
2018 53.86 Million HKD 28.33%
2017 53.24 Million HKD 7.32%
2016 47.15 Million HKD 13.63%
2015 41.49 Million HKD 0.0%

Peer EBITDA Comparison of Kato (Hong Kong) Holdings Limited

Name EBITDA EBITDA Difference
Aidigong Maternal & Child Health Limited 68.84 Million HKD -94.067%
UMP Healthcare Holdings Limited 161.98 Million HKD 17.515%
Human Health Holdings Limited 104.06 Million HKD -28.393%
EuroEyes International Eye Clinic Limited 292.1 Million HKD 54.259%
Bamboos Health Care Holdings Limited 52.75 Million HKD -153.253%
Beijing Health (Holdings) Limited -44.19 Million HKD 402.349%
C-MER Eye Care Holdings Limited 359.88 Million HKD 62.874%
Town Health International Medical Group Limited 53.5 Million HKD -149.736%
Medicskin Holdings Limited 6.77 Million HKD -1871.827%
Hang Chi Holdings Limited 81.58 Million HKD -63.765%